CAUTION — Investigational Device. Limited by Federal (or United States) law to investigational use only. Approved for use in Canada only.
26th Annual European Association of Urology Congres
In a preliminary pilot study we have been able to show that Low-Intensity Shock Wave Therapy (LI-ESWT) has a valuable effect on erectile function in patients responding to PDE5i’s. The aim of this study was to validate these results in a double-blind sham-controlled manner on a larger group of ED patients.
Download the Study
Download the Study (with visual data)
14th World Meeting of the International Society for Sexual Medicine
To evaluate the effect of low-intensity extracorporeal shock wave therapy (ESWT) on erectile function, in patients with vasculogenic ED. Download the Study.
13th Congress of the European Society for Sexual Medicine
Low-Intensity Extracorporeal Shock Wave Therapy (LI- ESWT) was shown to have a beneficial effect on ED patients responding to PDE5i’s. The aim of this study was to assess its effect on PDE5i’s non- responders.
Men’s Health World Congress
Our aim was to evaluate the efficacy of EDSWT on men with Erectile Dysfunction and analyze its role in the management of ED.
Treatment for Erectile Dysfunction in Severe ED Patients
Low-intensity shock wave therapy (LI-ESWT) has been reported as an effective treatment in men with mild and moderate erectile dysfunction (ED).The aim of this study is to determine the efficacy of LI-ESWT in severe ED patients who were poor responders to phosphodiesterase type 5 inhibitor (PDE5i) therapy.
Sponsoring Trial Site:
Our mission here at University Urology Associates is to render the absolute best in urologic specialty care to our patients through decades of experience, cutting edge technology, and medical research.